In patients with FTD, peripheral GFAP levels were consistently lower compared to those with Alzheimer’s disease (AD), as observed in plasma and serum across seven studies [16,18,19,20,24,25,27,80,100] (Supplementary Table S2). Here, GFAP is linked to early-onset autosomal dominant Alzheimer disease.